News
The NLRP3 inflammasome is implicated in a host ... in preclinical development but being eyed as a possible treatment for multiple sclerosis.
which has just reported phase 1 results with its first two NLRP3 inhibitors, and ZyVersa Therapeutics with preclinical-stage candidate IC 100 that is being considered for multiple sclerosis.
6d
MedPage Today on MSNScreening for Depression and Anxiety in Multiple SclerosisTo build a model that used routine clinical information to screen for anxiety and depression, Patten's group studied 828 MS ...
In recently published research in the journal Neurology, the team tracked records for 4,593 people living with multiple sclerosis from 2019 to 2020, 673 in rural areas and 3,920 in urban centers.
2d
News-Medical.Net on MSN2025 Best Practices Update released for managing MS in a changing landscapeKeeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).
Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...
Dr Pavan Bhargava gives insights on earlier diagnosis, ocrelizumab safety in pregnancy, and promising anti-aging effects of diet in RRMS.
Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...
2d
News-Medical.Net on MSNDiscovery sheds light on protein's role in myelin formation and schizophreniaResearch published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...
A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results